Kinetic scheduling of vincristine (NSC-67574) and bleomycin (NSC-125066) in patients with lung cancer and other malignant tumors.
D000367:Age Factors; D001761:Bleomycin / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D008171:Lung Diseases / Q000139:chemically induced; D008175:Lung Neoplasms / Q000097:blood / Q000188:drug therapy*; D008875:Middle Aged; D009362:Neoplasm Metastasis; D012871:Skin Diseases / Q000139:chemically induced; D013997:Time Factors; D014750:Vincristine / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use
D001761:Bleomycin; D014750:Vincristine